The FDA has approved Talicia, the first rifabutin-based treatment for Helicobacter pylori (H pylori) infection in adults. Each delayed-release capsule of Talicia contains omeprazole 10 mg, amoxicillin 250 mg, and rifabutin 12.5 mg.
https://t.co/8nYeUV9LzS